Financials

Discussions Technicals Seasonals

6932 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to MERCURY BIOPHARMACEUTICAL CORPORATI operating, investing, and financing activities

6932 free cash flow for H2 24 is -29.55 M TWD. For 2024, 6932 free cash flow was -44.73 M TWD and operating cash flow was -34.71 M TWD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—